A potent DNA synthesis inhibitor expressed by the immortal cell line SUSM-1

A L Spiering1, J R Smith, O M Pereira-Smith

  • 1Roy M. and Phyllis Gough Huffington Center on Aging, Baylor College of Medicine, Houston, Texas 77030.

Insights

Immortalized human cells produce DNA synthesis inhibitors that affect young cells. These cells, unlike normal ones, do not respond to their own inhibitors, suggesting a mechanism for escaping senescence.

Area of Science:

  • Cell Biology
  • Molecular Biology
  • Aging Research

Background:

  • Quiescent and senescent human fibroblasts produce DNA synthesis inhibitor proteins.
  • Young, proliferating fibroblasts respond to these inhibitors but do not produce them.

Purpose of the Study:

  • To investigate the production and activity of DNA synthesis inhibitors in the immortal cell line SUSM-1.
  • To determine if immortal cells respond to the inhibitors they produce.

Main Methods:

  • Analysis of DNA synthesis inhibitory activity in crude extracts from SUSM-1 cells.
  • Testing the response of SUSM-1 cells and other immortal cell lines to the SUSM-1 inhibitor.

Main Results:

  • SUSM-1 cells produce a potent DNA synthesis inhibitor, effective at lower concentrations than those from senescent or quiescent cells.
  • SUSM-1 cells and three other immortal cell lines tested were incapable of responding to the inhibitor they produced.
  • HeLa cells showed a partial response to the SUSM-1 inhibitor.

Conclusions:

  • The findings suggest that immortal cells like SUSM-1 may evade senescence by losing a receptor or cofactor for DNA synthesis inhibitors.
  • This mechanism could explain how cells achieve immortality and escape the finite lifespan observed in normal fibroblasts.

Related Concept Videos

Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Inhibitors of Bacterial DNA Synthesis01:28

Inhibitors of Bacterial DNA Synthesis

Bacterial pathogens depend on precise and efficient DNA replication to sustain infection. Two type II topoisomerases—DNA gyrase and topoisomerase IV—are critical to this process, as they resolve DNA supercoiling and unlink chromosomes during replication. Fluoroquinolones, synthetic derivatives of quinolones, exploit this mechanism by stabilizing the transient DNA–enzyme cleavage complex, preventing strand religation, and causing lethal double-strand breaks. These antibiotics are selectively...
Antiviral Nucleoside Inhibitors01:22

Antiviral Nucleoside Inhibitors

Antiviral Nucleoside InhibitorsAntiviral nucleoside inhibitors are structural analogs of natural nucleosides that interfere with viral DNA or RNA synthesis. These compounds selectively target viral polymerases due to their resemblance to host nucleosides, thereby disrupting viral genome replication.Mechanism of Acyclovir ActionAcyclovir is a guanosine analog with a three-carbon acyclic side chain. It selectively targets herpes simplex virus type 1 (HSV-1), herpes simplex virus type 2 (HSV-2),...